Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.64
-0.02 (-0.30%)
At close: Sep 1, 2026, 4:00 PM EDT
6.69
+0.05 (0.75%)
After-hours: Sep 1, 2026, 7:54 PM EDT

Nuvation Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,3313,0728953314191,851
Market Cap Growth
129.35%243.11%170.80%-21.16%-77.35%779.62%
Enterprise Value
2,0872,731357-284-2501,059
Last Close Price
6.668.962.661.511.928.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.9148.83113.71---
PB Ratio
9.1810.051.930.550.642.48
P/TBV Ratio
9.7010.431.950.550.642.48

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
12.4743.4245.39---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.640.220.020.010.010.00
Net Debt / Equity Ratio
-0.96-1.51-1.06-1.00-1.00-1.02
Net Debt / EBITDA Ratio
1.812.192.966.105.498.53
Net Debt / FCF Ratio
2.022.663.788.926.8111.13
Asset Turnover
0.240.110.01---
Quick Ratio
7.986.678.9144.0050.4145.40
Current Ratio
8.376.959.0444.1150.7045.62
Return on Equity (ROE)
-47.81%-53.18%-106.27%-12.03%-14.87%-18.07%
Return on Assets (ROA)
-12.36%-23.46%-18.02%-9.64%-10.33%-11.21%
Return on Capital Employed (ROCE)
-20.90%-41.60%-34.70%-16.40%-18.20%-11.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.34%-6.66%-63.44%-22.93%-24.85%-4.69%
FCF Yield
-5.12%-5.66%-14.59%-20.59%-23.01%-3.70%
Buyback Yield / Dilution
-4.49%-27.07%-22.79%-1.00%-9.52%-102.90%
SEC Filings: 10-K · 10-Q